Shell Asset Management’s Triumph Financial Inc TFIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$13K Sell
252
-658
-72% -$38.8K ﹤0.01% 1091
2025
Q2
$50K Sell
910
-101
-10% -$5.62K ﹤0.01% 1146
2025
Q1
$58K Sell
1,011
-44
-4% -$3.21K ﹤0.01% 1127
2024
Q4
$96K Hold
1,055
﹤0.01% 1055
2024
Q3
$84K Buy
+1,055
New +$88.1K ﹤0.01% 1086
2024
Q1
$91K Sell
1,117
-125
-10% -$9.44K ﹤0.01% 1044
2023
Q4
$100K Sell
1,242
-375
-23% -$25.4K ﹤0.01% 1059
2023
Q3
$105K Sell
1,617
-25
-2% -$1.65K ﹤0.01% 1081
2023
Q2
$100K Sell
1,642
-9
-0.5% -$495 ﹤0.01% 1119
2023
Q1
$96K Sell
1,651
-6
-0.4% -$344 ﹤0.01% 1111
2022
Q4
$81K Sell
1,657
-337
-17% -$18.2K ﹤0.01% 1207
2022
Q3
$108K Sell
1,994
-522
-21% -$34.3K ﹤0.01% 1206
2022
Q2
$157K Buy
2,516
+4
+0.2% +$283 ﹤0.01% 1176
2022
Q1
$236K Buy
+2,512
New +$247K 0.01% 1128

Other funds holding TFIN

Shell Asset Management's TFIN Position: Q3 2025 in Review

Shell Asset Management reduced its Triumph Financial Inc (TFIN) stake by 72% in Q3 2025, selling an estimated $38.8K and leaving 252 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

Shell Asset Management first reported a position in TFIN in Q1 2022 and has held it in 14 quarters since. The position peaked at $236K in Q1 2022. 194 funds tracked by Wall St. Rank hold TFIN as of Q3 2025.

  • Shell Asset Management held 252 shares of Triumph Financial Inc worth $13K as of Q3 2025.
  • Shell Asset Management sold 658 Triumph Financial Inc shares in Q3 2025, an estimated $38.8K.
  • Triumph Financial Inc made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1091 holding.
  • Shell Asset Management first reported a position in Triumph Financial Inc in Q1 2022 and has held it in 14 quarters since.
  • Shell Asset Management's Triumph Financial Inc position peaked at $236K in Q1 2022.
  • 194 funds tracked by Wall St. Rank held Triumph Financial Inc as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.